Cancer treatments

Two more studies are reported this week continue to show the inability of oncologists to consider the pain and adverse effects on quality of life from both a cancer and the treatment of that cancer.  One study was on the value of dual radiotherapy for the poor risk esophageal cancer.  The other was on combined therapies for treatment of prostatic cancer.  In both these studies so-called significant improvements led to only a few weeks of extended life while no data was provided on the resulting quality of that life.  It certainly makes money for the pharmaceutical companies whose products were used in these studies and it is high time that research funding was removed from any study that fails to consider the quality of life as an outcome measure.
Source: Dr. Buttery's Public Health BLOG - Category: Epidemiologists Authors: Tags: Chronic Disease epidemiology policy research Technology Source Type: blogs